March 2020

ACC Issues Coronavirus Bulletin
On February 14, 2020, the American College of Cardiology (ACC) released a clinical bulletin addressing the cardiac implications of the current epidemic associated with the novel Wuhan coronavirus, or COVID-19. The crucial message to clinicians in this recent clinical bulletin is that patients with underlying cardiovascular disease are potentially at increased risk if they contract COVID-19. Read more about the bulletin here.


Agent May Diminish Repeat Cardiovascular Events 
The oral antidiabetic metformin is one of the most frequently prescribed agents for type 2 diabetes mellitus (T2DM). Various studies have explored the potential cardioprotective benefits of metformin. Since patients with type 2 diabetes have a greater incidence of recurrent cardiovascular disease (CVD), researchers evaluated recurrent CVD after primary diagnosis of acute cardiovascular syndrome in patients with T2DM. Findings from a recent study suggest that the use of metformin can prevent repeat cardiovascular episodes in those with T2DM. Read more.  

Investigating Cardiovascular Disease Risk & Inflammatory Arthritis
The presence of inflammatory arthritis appears to be a critical factor in increasing the risk of developing cardiovascular disease (CVD), according to a new study. Researchers evaluated the prevalence percentage and frequency rate of cardiovascular morbidity in patients with inflammatory arthritis only, patients with inflammatory arthritis coexistent with another autoimmune disorder, and controls to determine whether the co-existence of multiple autoimmune disorders is associated with an amplified risk of CVD. Read more.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App